Virologic diagnosis, viral monitoring, and treatment of Epstein-Barr virus infectious mononucleosis

Current Infectious Disease Reports

Volumn 6, Issue 3, 2004, Pages 200-207

  Jenson, Hal B ^a  

^a EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ANTIVIRUS AGENT; CORTICOSTEROID; DESCICLOVIR; DEXAMETHASONE; HETEROPHILE ANTIBODY; METHYLPREDNISOLONE; PREDNISONE; VALACICLOVIR; VIRUS VACCINE;

CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; EPSTEIN BARR VIRUS; HERPES VIRUS INFECTION; HUMAN; IMMUNE DEFICIENCY; IMMUNOFLUORESCENCE TEST; INFECTIOUS MONONUCLEOSIS; OROPHARYNX; REVIEW; VIRUS DIAGNOSIS; VIRUS REPLICATION; VIRUS SHEDDING;

EID: 3142512727     PISSN: 15233847     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11908-004-0009-2     Document Type: Review

References (48)

1. Miyashita EM, Yang B, Babcock GJ, Thorley-Lawson DA: Identification of the site of Epstein-Barr virus persistence in vivo as a resting B cell. J Virol 1997, 71:4882-4891.
2. Ikuta K, Satoh Y, Hoshikawa Y, Sairenji T: Detection of Epstein-Barr virus in salivas and throat washings in healthy adults and children. Microbes Infection 2000, 2:115-120.
3. Reichart PA, Langford A, Gelderblom HR, et al.: Oral hairy leukoplakia: observations in 95 cases and review of the literature. J Oral Pathol Med 1989, 18:410-415.
4. Barberà JA, Hayashi S, Hegele RC, Hogg JC: Detection of Epstein-Barr virus in lymphocytic interstitial pneumonia by in situ hybridization. Am Rev Respir Dis 1992, 145:940-946.
5. Miller G, Grogan E, Rowe D, et al.: Selective lack of antibody to a component of EB nuclear antigen in patients with chronic active Epstein-Barr virus infection. J Infect Dis 1987, 156:26-35.
6. Latour S, Veillette A: Molecular and immunological basis of X-linked lymphoproliferative disease. Immunol Rev 2003, 192:212-224.
7. Fleisher G, Henle W, Henle G, et al.: Primary infection with Epstein-Barr virus in infants in the United States: clinical and serologic observations. J Infect Dis 1979, 139:553-558.
8. Sumaya CV, Ench Y: Epstein-Barr virus infectious mononucleosis in children. II. Heterophil antibody and viral-specific responses. Pediatrics 1985, 75:1011-1019.
9. Jenson HB, Ench Y: Epstein-Barr virus. In Manual of Clinical Laboratory Immunology, edn 6. Edited by Rose NR, Hamilton RG, Detrick B. Washington, DC: American Society for Microbiology Press; 2002:615-626.
10. Bruu AL, Hjetland R, Holter E, et al.: Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol 2000, 7:451-456.
11. de Schryver A, Klein G, Hewetson J, et al.: Comparison of EBV neutralization tests based on abortive infection or transformation of lymphoid cells and their relation to membrane reactive antibodies (anti-MA). Int J Cancer 1974, 13:353-362.
12. Rocchi G, Felici A, Ragona G, Heinz A: Quantitative evaluation of Epstein-Barr-virus-infected mononuclear peripheral blood leukocytes in infectious mononucleosis. N Engl J Med 1977, 296:132-134.
13. Ambinder RF, Mann RB: Detection and characterization of Epstein-Barr virus in clinical specimens. Am J Pathol 1994, 145:239-252.
14. Diaz-Mitoma F, Preiksaitis JK, Leung WC, Tyrrell DL: DNA-DNA dot hybridization to detect Epstein-Barr virus in throat washings. J Infect Dis 1987, 155:297-303.
15. Walling DM, Raab-Traub N: Epstein-Barr virus intrastrain recombination in oral hairy leukoplakia. J Virol 1994, 68:7909-7917.
16. Raab-Traub N, Flynn K: The structure of the termini of the Epstein-Barr virus as a marker of clonal cellular proliferation. Cell 1986, 47:883-889.
17. Raab-Traub N, Webster-Cyriaque J: Epstein-Barr virus infection and expression in oral lesions. Oral Dis 1997, 1:(Suppl 3):S164-S170.
18. Niesters HGM, van Esser J, Fries E, et al.: Development of a real-time quantitative assay for detection of Epstein-Barr virus. J Clin Microbiol 2000, 38:712-715.
19. Kimura H, Morita M, Yabuta Y, et al.: Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay. J Clin Microbiol 1999, 37:132-136.
20. Kimura H, Nishikawa K, Hoshino Y, et al.: Monitoring of cell-free viral DNA in primary Epstein-Barr virus infection. Med Microbiol Immunol (Berl) 2000, 188:197-202.
21. van Laar JA, Buysse CM, Vossen AC, et al.: Epstein-Barr viral load assessment in immunocompetent patients with fulminant infectious mononucleosis. Arch Intern Med 2002, 162:837-839.
22. Lo YM, Chan LY, Lo KW, et al.: Quantitative analysis of cell-free Epstein-Barr virus DNA in plasma of patients with nasopharyngeal carcinoma. Cancer Res 1999, 59:1188-1191.
23. Lo YM, Chan AT, Chan LY, et al.: Molecular prognostication of nasopharyngeal carcinoma by quantitative analysis of circulating Epstein-Barr virus DNA. Cancer Res 2000, 60:6878-6881.
24. Lo YM: Quantitative analysis of Epstein-Barr virus DNA in plasma and serum: applications to tumor detection and monitoring. Ann NY Acad Sci 2001, 945:68-72.
25. Pitetti RD, Laus S, Wadowsky RM: Clinical evaluation of a quantitative real time polymerase chain reaction assay for diagnosis of primary Epstein-Barr virus infection in children. Pediatr Infect Dis J 2003, 22:736-739.
26. Ikuta K, Saiga K, Deguchi M, Sairenji T: Epstein-Barr virus DNA is detected in peripheral blood mononuclear cells of EBV-seronegative infants with infectious mononucleosis-like symptoms. Virus Genes 2003, 26:165-173.
27. Berger C, Day P, Meier G, et al.: Dynamics of Epstein-Barr virus DNA levels in serum during EBV-associated disease. J Med Virol 2001, 64:505-512.
28. Campe H, Jaeger G, Abou-Ajram C, et al.: Serial detection of Epstein-Barr virus DNA in sera and peripheral blood leukocyte samples of pediatric renal allograft recipients with persistent mononucleosis-like symptoms defines patients at risk to develop post-transplant lymphoproliferative disease. Pediatr Transplant 2003, 7:46-52.
29. Leung E, Shenton BK, Jackson G, et al.: Use of real-time PCR to measure Epstein-Barr virus genomes in whole blood. J Immunol Methods 2002, 270:259-267.
30. Weiss LM, Movahed LA, Warnke RA, Sklar J: Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease. N Engl J Med 1989, 320:502-506.
31. Pagano JS, Sixbey JW, Lin JC: Acyclovir and Epstein-Barr virus infection. J Antimicrob Chemother 1983, 12(Suppl B):113-121.
32. Andersson J, Britton S, Ernberg I, et al.: Effect of acyclovir on infectious mononucleosis: a double-blind, placebo-controlled study. J Infect Dis 1986, 153:283-290.
33. Andersson J, Sköldenberg B, Henle W, et al.: Acyclovir treatment in infectious mononucleosis: a clinical and virological study. Infection 1987, 15:S14-S20.
34. van der Horst C, Joncas J, Ahronheim G, et al.: Lack of effect of peroral acyclovir for the treatment of acute infectious mononucleosis. J Infect Dis 1991, 164:788-792.
35. Tynell E, Aurelius E, Brandell A, et al.: Acyclovir and prednisolone treatment of acute infectious mononucleosis: a multicenter, double-blind, placebo-controlled study. J Infect Dis 1996, 174:324-331.
36. Torre D, Tambini R: Acyclovir for treatment of infectious mononucleosis: a meta-analysis. Scand J Infect Dis 1999, 31:543-547.
37. Scully C, Porter SR, Di Alberti L, et al.: Detection of Epstein-Barr virus in oral scrapes in HIV infection, in hairy leukoplakia, and in healthy non-HIV-infected people. J Oral Pathol Med 1998, 27:480-482.
38. Resnick L, Herbst JS, Ablashi DV, et al.: Regression of oral hairy leukoplakia after orally administered acyclovir therapy. JAMA 1988, 259:384-388.
39. Herbst JS, Morgan J, Raab-Traub N, Resnick L: Comparison of the efficacy of surgery and acyclovir therapy in oral hairy leukoplakia. J Am Acad Dermatol 1989, 21:753-756.
40. Greenspan D, De Souza YG, Conant MA, et al.: Efficacy of desciclovir in the treatment of Epstein-Barr virus infection in oral hairy leukoplakia. J Acquir Immune Defic Syndr 1990, 3:571-578.
41. Walling DM, Flaitz CM, Nichols CM: Epstein-Barr virus replication in oral hairy leukoplakia: response, persistence, and resistance to treatment with valacyclovir. J Infect Dis 2003, 188:883-890.
42. Walling DM, Edmiston SN, Sixbey JW, et al.: Coinfection with multiple strains of the Epstein-Barr virus in human immunodeficiency virus-associated hairy leukoplakia. Proc Natl Acad Sci USA 1992, 89:6560-6564.
43. Walling DM, Clark NM, Markovitz DM, et al.: Epstein-Barr virus coinfection and recombination in non-human immunodeficiency virus-associated oral hairy leukoplakia. J Infect Dis 1995, 171:1122-1130.
44. Wohl DL, Isaacson JE: Airway obstruction in children with infectious mononucleosis. Ear Nose Throat J 1995, 74:630-638.
45. Radel EG, Schorr JB: Thrombocytopenic purpura with infectious mononucleosis. J Pediatr 1963, 63:46-60.
46. Steeper TA, Horwitz CA, Moore SB, et al.: Severe thrombocytopenia in Epstein-Barr virus-induced mononucleosis. West J Med 1989, 150:170-173.
47. Whitelaw F, Brook MG, Kennedy N, Weir WR: Haemolytic anaemia complicating Epstein-Barr virus infection. Br J Clin Pract 1995, 49:212-213.
48. Waldo RT: Neurologic complications of infectious mononucleosis after steroid therapy. South Med J 1981, 74:1159-1160.